Medicare Enrolled
Dr. Seth Benkel, M.D.
Hematology & Oncology · New City, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Benkel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Benkel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Benkel
Dr. Seth Benkel is a hematology & oncology specialist in New City, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Benkel performed 110,749 Medicare services across 11,532 unique beneficiaries.
Between the years covered by Open Payments, Dr. Benkel received a total of $12,580 from 65 pharmaceutical and/or device companies across 623 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Benkel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 5% volume in NY
$12,580 industry payments
Medicare Practice Summary
Medicare Utilization ↗110,749
Medicare services
Top 5% in NY for hematology & oncology
11,532
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5,537 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
67,200 | $0 | $1 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
12,080 | $1 | $5 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
6,010 | $5 | $8 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,871 | $8 | $15 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,868 | $5 | $5 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
2,650 | $9 | $20 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,868 | $10 | $15 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
1,868 | $6 | $10 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
1,665 | $13 | $25 |
| Iron level test | 1,665 | $6 | $12 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
1,664 | $9 | $15 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,552 | $76 | $127 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
1,388 | $15 | $55 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
1,384 | $14 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,007 | $112 | $210 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
457 | $13 | $100 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
359 | $62 | $150 |
| Homocysteine level test A blood test that measures the amount of homocysteine, an amino acid, in the body. |
221 | $18 | $45 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
219 | $16 | $25 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
219 | $4 | $15 |
| Thyroxine (T4) level test A blood test that measures the total amount of thyroxine, a thyroid hormone, in your body. |
215 | $7 | $15 |
| Thyroid hormone evaluation A blood test to measure the levels of thyroid hormones in the body. This evaluation helps assess how well the thyroid gland is functioning. |
212 | $6 | $15 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
167 | $1 | $10 |
| Manual red blood cell count A laboratory test that manually counts the number of red blood cells in a blood sample. |
157 | $4 | $10 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
156 | $145 | $260 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
137 | $19 | $26 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
107 | $25 | $50 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
96 | $19 | $30 |
| New patient office visit, complex (60-74 min) | 71 | $197 | $349 |
| PSA test (prostate cancer screening) | 52 | $18 | $30 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
49 | $159 | $250 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
38 | $79 | $160 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
22 | $26 | $50 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
22 | $108 | $215 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $52 | $137 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
12 | $170 | $501 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
77.6% medium
22.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,580
Total received (2018-2024)
Avg $1,797/year across 7 years
Top 22% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
623
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,887 (86.5%)
Other
Charitable contributions, space rental, and other categories
$1,294 (10.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$399 (3.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$901
2023
$1,332
2022
$1,601
2021
$2,270
2020
$1,184
2019
$2,923
2018
$2,368
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$201
E.R. Squibb & Sons, L.L.C.
$108
Takeda Pharmaceuticals U.S.A., Inc.
$84
ABBVIE INC.
$57
GlaxoSmithKline, LLC.
$52
BeiGene USA, Inc.
$51
Merck Sharp & Dohme LLC
$50
PFIZER INC.
$46
AstraZeneca Pharmaceuticals LP
$46
Alexion Pharmaceuticals, Inc.
$30
Daiichi Sankyo Inc.
$29
Lilly USA, LLC
$25
Janssen Pharmaceuticals, Inc
$24
Stemline Therapeutics Inc.
$23
Genentech USA, Inc.
$22
Azurity Pharmaceuticals, Inc.
$21
Celgene Corporation
$18
Janssen Biotech, Inc.
$14
Top 3 companies account for 43.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,348
Janssen Biotech, Inc.
$771
AstraZeneca Pharmaceuticals LP
$763
E.R. Squibb & Sons, L.L.C.
$710
PFIZER INC.
$616
Takeda Pharmaceuticals U.S.A., Inc.
$541
Tosoh Bioscience, Inc.
$486
Merck Sharp & Dohme Corporation
$454
Amgen Inc.
$451
Genentech USA, Inc.
$431
Janssen Pharmaceuticals, Inc
$408
Celgene Corporation
$379
Lilly USA, LLC
$342
GENZYME CORPORATION
$327
Incyte Corporation
$285
Astellas Pharma US Inc
$218
Pharmacyclics LLC, An AbbVie Company
$214
Bayer HealthCare Pharmaceuticals Inc.
$191
Boehringer Ingelheim Pharmaceuticals, Inc.
$188
Seagen Inc.
$185
NOVARTIS PHARMACEUTICALS CORPORATION
$167
GlaxoSmithKline, LLC.
$136
Merck Sharp & Dohme LLC
$133
Gilead Sciences, Inc.
$112
BeiGene USA, Inc.
$92
Exelixis Inc.
$89
MorphoSys, US Inc.
$86
EISAI INC.
$82
AbbVie, Inc.
$77
ABBVIE INC.
$76
Seattle Genetics, Inc.
$74
Daiichi Sankyo Inc.
$67
Regeneron Healthcare Solutions, Inc.
$67
Taiho Oncology, Inc.
$63
Karyopharm Therapeutics Inc.
$56
Dova Pharmaceuticals
$55
Teva Pharmaceuticals USA, Inc.
$54
Rigel Pharmaceuticals, Inc.
$51
Bayer Healthcare Pharmaceuticals Inc.
$49
ADC Therapeutics America, Inc.
$48
PUMA BIOTECHNOLOGY, INC.
$47
Alexion Pharmaceuticals, Inc.
$46
Kyowa Kirin, Inc.
$46
EMD Serono, Inc.
$42
Pharmacyclics LLC, an AbbVie Company
$39
Blueprint Medicines Corporation
$38
Puma Biotechnology, Inc.
$28
Eisai Inc.
$25
Pharmacosmos Therapeutics Inc.
$24
TAIHO ONCOLOGY, INC.
$23
Apellis Pharmaceuticals, Inc.
$23
Stemline Therapeutics Inc.
$23
AbbVie Inc.
$23
Advanced Accelerator Applications
$21
Azurity Pharmaceuticals, Inc.
$21
Mirati Therapeutics, Inc.
$20
Helsinn Therapeutics (U.S.), Inc.
$20
SECURA BIO, INC.
$19
TOLMAR Pharmaceuticals, Inc.
$18
CTI BioPharma Corp.
$17
PORTOLA PHARMACEUTICALS, INC.
$17
Verastem, Inc.
$15
Clovis Oncology, Inc.
$13
TESARO, Inc.
$13
Epizyme, Inc.,
$13
Top 3 companies account for 30.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AIA-PACK · AKYNZEO · ALIMTA · ALUNBRIG · ANDEXXA · AYVAKIT · Alecensa · Aliqopa · Avastin · BENDEKA · BOSULIF · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · CEA · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · Doptelet · ELIGARD · ELIQUIS · ELITEK · EMEND · ENHERTU · ERBITUX · Empaveli · Enhertu · Erleada · FASLODEX · Fabhalta · GAZYVA · GILOTRIF · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · INVOKAMET · INVOKANA · Imbruvica · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nplate · Nubeqa · OCREVUS · OJJAARA · OPDIVO · OPDUALAG · Orserdu · PADCEV · PIQRAY · POTELIGEO · PROMACTA · Perjeta · Pomalyst · REBLOZYL · Revlimid · Rubraca · SANDOSTATIN · SCEMBLIX · ST · STANDARDIZATION TEST CUP · SUTENT · Stivarga · TABRECTA · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · Tavalisse · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VIVIMUSTA · Vectibix · Venclexta · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xofigo · Xospata · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
180
Per 100K population
53.1
County median income
$110,631
Nearest hospital
HELEN HAYES HOSPITAL
4.0 mi
4.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Benkel is a mixed practice specialist, with above-average Medicare volume (top 5% in NY), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Benkel experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Benkel performed 67,200 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Benkel receive payments from pharmaceutical companies?
Yes. Dr. Benkel received a total of $12,580 from 65 companies across 623 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Benkel's costs compare to other hematology & oncology specialists in New City?
Dr. Benkel's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Benkel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in New City
Browse hematology & oncology specialists in New City ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NY
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NY
Which NY hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology